Lymphocyte predominance in blood, pleural fluid, and tumour stroma; a prognostic marker in pleural mesothelioma

Lymphocyte predominance in blood, pleural fluid, and tumour stroma; a prognostic marker in pleural mesothelioma

Abstract Background As promising novel treatments develop for malignant pleural mesothelioma (MPM), early prognostication has become increasingly important. Circulating and local inflammatory cells are known to play a significant role in other tumour types. We assessed the proportion of lymphocyte p...

Full description

Bibliographic Details
Main Authors: Duneesha De Fonseka, David T. Arnold, Anna J. Morley, Mary Brett, Nidhi Bhatt, Anthony Edey, Richard Daly, Anna C. Bibby, Nick A. Maskell
Format: Article
Language:English
Published: BMC 2022-04-01
Series:BMC Pulmonary Medicine
Subjects:
Neutrophils
Lymphocytes
NLR
Pleural fluid
Mesothelioma
Online Access:https://doi.org/10.1186/s12890-022-01968-2

Internet

https://doi.org/10.1186/s12890-022-01968-2

Similar Items